| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Review Article |
St John's Institute of Dermatology, Guy's and St Thomas' Hospital, Westminister Bridge Road, London, SEI 7EH, UK
Correspondence to: Dr Mahreen Ameen, St John's Institute of Dermatology, Guy's and St Thomas' Hospital, Westminister Bridge Road, London, SEI 7EH, UK Email: mahreenameen{at}hotmail.com
Mycetomas are chronic, granulomatous, subcutaneous infections caused by traumatic inoculation into the skin of either the actinomycetes bacteria or the eumycetes fungi, giving rise to actinomycetomas and eumycetomas, respectively. They are endemic in the tropics afflicting mainly those of low socio-economic status and men working in agriculture. The disease is slowly progressive and can cause bone involvement, which can result in considerable disability. Late presentation is not uncommon making them notoriously difficult to manage. This article highlights the important aspects of their management and developments in drug therapy.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?